|
|
|
|
LEADER |
01521naa a2200349 i 4500 |
001 |
NSK01001091120 |
003 |
HR-ZaNSK |
005 |
20210219085002.0 |
007 |
ta |
008 |
210219s2018 ci a | |0|| ||eng |
035 |
|
|
|a (HR-ZaNSK)001091120
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
042 |
|
|
|a croatica
|
044 |
|
|
|a ci
|c hr
|
080 |
1 |
|
|a 616
|2 2011
|
100 |
1 |
|
|a Pavlov, Marin,
|c liječnik
|4 aut
|
245 |
1 |
0 |
|a Plasminogen activator inhibitor-1 activity and longterm outcome in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention :
|b a prospective cohort study /
|c Marin Pavlov, Vjeran Nikolić-Heitzler, Zdravko Babić, Milan Milošević, Krešimir Kordić, Ivana Ćelap, Vesna Degoricija.
|
300 |
|
|
|b Ilustr.
|
500 |
|
|
|a Tematski blok: Gastroesophageal refux disease, Barrett esophagus, and esophagel adenocarcinoma - where do we stand?
|
504 |
|
|
|a Bibliografija: 31 jed.
|
653 |
|
0 |
|a Srčani infarkt
|a Aktivatori plazminogena
|a Perkutana koronarna intervencija
|
653 |
|
6 |
|a Kohortna studija
|
700 |
1 |
|
|a Nikolić Heitzler, Vjeran
|4 aut
|
700 |
1 |
|
|a Babić, Zdravko
|4 aut
|
700 |
1 |
|
|a Milošević, Milan,
|c liječnik
|4 aut
|
700 |
1 |
|
|a Kordić, Krešimir
|4 aut
|
700 |
1 |
|
|a Ćelap, Ivana
|4 aut
|
700 |
1 |
|
|a Degoricija, Vesna
|4 aut
|
773 |
0 |
|
|t Croatian medical journal
|x 0353-9504
|g 59 (2018), 3 ; str. 108-117
|w nsk.(HR-ZaNSK)000006721
|
981 |
|
|
|b B08/18
|
998 |
|
|
|b gtao2102
|
856 |
4 |
1 |
|u https://hrcak.srce.hr/237473
|y Elektronička verzija članka
|